Iconovo AB is a Lund-based pharma innovation company specializing in the development of dry powder inhalers for the pharmaceutical industry. Their portfolio of standardized, cost-effective inhaler platforms enables efficient drug delivery for respiratory and systemic diseases. Founded in 2014 at Ideon Science Park, Iconovo employs around 25 people and works with global pharmaceutical companies to bring new inhaled therapies to market. Listed on Nasdaq First North.
iconovo.sePart of: Skåne Startup map